Abstract
Primary cardiac tumors in children are rare and mostly benign but can cause significant cardiovascular complications, including arrhythmias. We present a rare case of fetal and neonatal refractory supraventricular tachycardia linked to a probable mitral valve hemangioma, resulting in severe neonatal and maternal morbidity. Despite challenges, pharmacological therapy ultimately successfully managed the condition, highlighting the importance of individualized treatment in such complex cases.